GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | 8/7/2026 4:44:55 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $26,000 +4.0% | Assets $12,731,000 | EPS -$0.43 | |
| AIM ImmunoTech Inc. (AIM) | 6/25/2026 8:56:13 AM | View | Proxy | SEC | Y 2025 | ||||||
| AIM ImmunoTech Inc. (AIM) | 5/15/2026 4:24:04 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $22,000 +37.5% | Assets $8,585,000 | EPS -$0.69 | |
| AIM ImmunoTech Inc. (AIM) | 3/27/2026 5:45:40 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $88,000 -48.2% | Assets $5,782,000 | EPS -$8.62 | |
| AIM ImmunoTech Inc. (AIM) | 11/18/2025 8:57:06 AM | View | Financials | Earnings | WIRE | 3Q 2025 | Rev $26,000 -25.7% | Assets $5,494,000 | EPS $1.57 | Export Earnings Model | |
| AIM ImmunoTech Inc. (AIM) | 11/17/2025 4:44:11 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $26,000 -25.7% | Assets $5,494,000 | EPS $1.57 | |
| AIM ImmunoTech Inc. (AIM) | 10/29/2025 4:35:02 PM | View | Proxy | SEC | Y 2024 | ||||||
| AIM ImmunoTech Inc. (AIM) | 8/15/2025 9:01:28 AM | View | Financials | Earnings | WIRE | 2Q 2025 | Rev $25,000 -50.0% | Assets $4,129,000 | EPS -$3.68 | Export Earnings Model | |
| AIM ImmunoTech Inc. (AIM) | 8/14/2025 4:36:52 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $25,000 -50.0% | Assets $4,129,000 | EPS -$3.68 | |
| AIM ImmunoTech Inc. (AIM) | 5/15/2025 4:55:01 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $16,000 -60.0% | Assets $6,248,000 | EPS -$0.05 | |
| AIM ImmunoTech Inc. (AIM) | 4/2/2025 4:47:10 PM | View | Proxy | SEC | Y 2024 | ||||||
| AIM ImmunoTech Inc. (AIM) | 3/27/2025 8:06:53 AM | View | Financials | Earnings | WIRE | Y 2024 | Rev $45,000 -30.8% | Assets $8,608,000 | EPS -$0.10 | Export Earnings Model | |
| AIM ImmunoTech Inc. (AIM) | 3/27/2025 7:22:35 AM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $170,000 -15.8% | Assets $8,608,000 | EPS -$0.31 | |
| AIM ImmunoTech Inc. (AIM) | 11/15/2024 7:31:12 AM | View | Financials | Earnings | WIRE | 3Q 2024 | Rev $35,000 -23.9% | Assets $13,588,000 | EPS -$0.06 | Export Earnings Model | |
| AIM ImmunoTech Inc. (AIM) | 11/14/2024 4:51:26 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $35,000 -23.9% | Assets $13,588,000 | EPS -$0.06 | |
| AIM ImmunoTech Inc. (AIM) | 11/6/2024 9:03:07 AM | View | Proxy | SEC | Y 2023 | ||||||
| AIM ImmunoTech Inc. (AIM) | 11/4/2024 7:01:22 AM | View | Proxy | SEC | Y 2023 | ||||||
| AIM ImmunoTech Inc. (AIM) | 8/16/2024 7:02:12 AM | View | Financials | Earnings | WIRE | 2Q 2024 | Rev $50,000 +19.0% | Assets $15,715,000 | EPS -$0.03 | Export Earnings Model | |
| AIM ImmunoTech Inc. (AIM) | 8/14/2024 5:16:28 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $50,000 +19.0% | Assets $15,715,000 | EPS -$0.03 | |
| AIM ImmunoTech Inc. (AIM) | 5/16/2024 7:32:09 AM | View | Financials | Earnings | WIRE | 1Q 2024 | Rev $40,000 -18.4% | Assets $16,189,000 | EPS -$0.12 | Export Earnings Model | |
| AIM ImmunoTech Inc. (AIM) | 5/15/2024 4:48:39 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $40,000 -18.4% | Assets $16,189,000 | EPS -$0.12 | |
| AIM ImmunoTech Inc. (AIM) | 4/2/2024 7:32:49 AM | View | Financials | Earnings | WIRE | Y 2023 | Rev $65,000 +16.1% | Assets $19,381,000 | EPS -$0.26 | Export Earnings Model | |
| AIM ImmunoTech Inc. (AIM) | 4/1/2024 6:18:20 AM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $202,000 +43.3% | Assets $19,381,000 | EPS -$0.60 | |
| AIM ImmunoTech Inc. (AIM) | 11/15/2023 7:31:54 AM | View | Financials | Earnings | WIRE | 3Q 2023 | Rev $46,000 +119.0% | Assets $27,861,000 | EPS -$0.16 | Export Earnings Model | |
| AIM ImmunoTech Inc. (AIM) | 11/14/2023 8:57:46 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $46,000 +119.0% | Assets $27,861,000 | EPS -$0.16 | |
| AIM ImmunoTech Inc. (AIM) | 11/6/2023 9:10:40 AM | View | Proxy | SEC | Y 2022 | ||||||
| AIM ImmunoTech Inc. (AIM) | 11/1/2023 5:03:39 PM | View | Proxy | SEC | Y 2022 | ||||||
| AIM ImmunoTech Inc. (AIM) | 8/15/2023 6:47:01 AM | View | Financials | Earnings | WIRE | 2Q 2023 | Rev $42,000 +40.0% | Assets $33,617,000 | EPS -$0.10 | Export Earnings Model | |
| AIM ImmunoTech Inc. (AIM) | 8/14/2023 5:17:10 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $42,000 +40.0% | Assets $33,617,000 | EPS -$0.10 | |
| AIM ImmunoTech Inc. (AIM) | 5/15/2023 8:46:40 AM | View | Financials | Earnings | WIRE | 1Q 2023 | Rev $49,000 +48.5% | Assets $37,462,000 | Export Earnings Model | ||
| AIM ImmunoTech Inc. (AIM) | 5/15/2023 6:30:45 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $49,000 +48.5% | Assets $37,462,000 | ||
| AIM ImmunoTech Inc. (AIM) | 4/3/2023 6:31:34 AM | View | Financials | Earnings | WIRE | Y 2022 | Rev $56,000 +12.0% | Assets $40,488,000 | Export Earnings Model | ||
| AIM ImmunoTech Inc. (AIM) | 3/31/2023 4:59:09 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $141,000 +4.4% | Assets $40,488,000 | ||
| AIM ImmunoTech Inc. (AIM) | 11/15/2022 7:02:11 AM | View | Financials | Earnings | WIRE | 3Q 2022 | Rev $21,000 -36.4% | Assets $46,285,000 | Export Earnings Model | ||
| AIM ImmunoTech Inc. (AIM) | 11/14/2022 4:48:40 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $21,000 -36.4% | Assets $46,285,000 | ||
| AIM ImmunoTech Inc. (AIM) | 9/28/2022 5:11:13 PM | View | Proxy | SEC | Y 2021 | ||||||
| AIM ImmunoTech Inc. (AIM) | 9/21/2022 5:20:51 PM | View | Proxy | SEC | Y 2021 | ||||||
| AIM ImmunoTech Inc. (AIM) | 9/19/2022 8:01:17 AM | View | Proxy | SEC | Y 2021 | ||||||
| AIM ImmunoTech Inc. (AIM) | 8/15/2022 8:19:55 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $30,000 +30.4% | Assets $50,884,000 | ||
| AIM ImmunoTech Inc. (AIM) | 5/13/2022 4:57:49 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $33,000 +17.9% | Assets $54,155,000 | ||
| AIM ImmunoTech Inc. (AIM) | 3/31/2022 1:17:42 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $135,000 -17.2% | Assets $57,699,000 | ||
| AIM ImmunoTech Inc. (AIM) | 11/16/2021 7:01:17 AM | View | Financials | Earnings | WIRE | 3Q 2021 | Rev $33,000 -8.3% | Assets $63,080,000 | Export Earnings Model | ||
| AIM ImmunoTech Inc. (AIM) | 11/15/2021 5:12:47 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $33,000 -8.3% | Assets $63,080,000 | ||
| AIM ImmunoTech Inc. (AIM) | 8/17/2021 4:31:20 PM | View | Proxy | SEC | Y 2020 | ||||||
| AIM ImmunoTech Inc. (AIM) | 8/17/2021 9:27:39 AM | View | Financials | Earnings | WIRE | 2Q 2021 | Rev $23,000 -42.5% | Assets $66,722,000 | Export Earnings Model | ||
| AIM ImmunoTech Inc. (AIM) | 8/16/2021 5:02:06 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $23,000 -42.5% | Assets $66,722,000 | ||
| AIM ImmunoTech Inc. (AIM) | 5/17/2021 5:28:25 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $28,000 -37.8% | Assets $74,089,000 | ||
| AIM ImmunoTech Inc. (AIM) | 3/31/2021 9:16:13 AM | View | Financials | Earnings | WIRE | Y 2020 | Rev $42,000 -16.0% | Assets $64,584,000 | EPS -$0.09 | Export Earnings Model | |
| AIM ImmunoTech Inc. (AIM) | 3/31/2021 6:12:46 AM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $163,000 +16.4% | Assets $64,584,000 | EPS -$0.45 | |
| AIM ImmunoTech Inc. (AIM) | 11/12/2020 4:51:57 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $36,000 -41.0% | Assets $64,164,000 | EPS -$0.08 | |
| AIM ImmunoTech Inc. (AIM) | 8/14/2020 5:15:29 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Rev: $40,000 +37.9% | Assets $50,123,000 | EPS -$0.11 | |
| AIM ImmunoTech Inc. (AIM) | 8/11/2020 5:25:20 PM | View | Proxy | SEC | Y 2019 | ||||||
| AIM ImmunoTech Inc. (AIM) | 5/14/2020 8:35:24 AM | Micro | View | Financials | 10-Q/A | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $45,000 | Assets $42,407,000 | EPS -$0.22 | |
| AIM ImmunoTech Inc. (AIM) | 5/14/2020 6:14:23 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $45,000 | Assets $42,407,000 | EPS -$0.22 | |
| AIM ImmunoTech Inc. (AIM) | 4/16/2020 5:01:10 PM | View | Presentation | SEC | 2Q 2020 | ||||||
| AIM ImmunoTech Inc. (AIM) | 3/30/2020 5:35:42 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $140,000 -61.9% | Assets $20,754,000 | EPS -$2.58 | |
| AIM ImmunoTech Inc. (AIM) | 3/12/2020 2:00:55 AM | View | Financials | Earnings | WIRE | Y 2019 | Rev $50,000 -79.2% | Assets $20,754,000 | EPS $1.83 | Export Earnings Model | |
| AIM ImmunoTech Inc. (AIM) | 11/14/2019 5:26:58 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Rev: $61,000 +60.5% | Assets $22,490,000 | EPS -$1.13 | |
| AIM ImmunoTech Inc. (AIM) | 10/30/2019 2:00:50 AM | View | Financials | Earnings | WIRE | 3Q 2019 | Rev $61,000 +60.5% | Assets $22,490,000 | EPS -$1.13 | Export Earnings Model | |
| HEMISPHERX BIOPHARMA INC (AIM) | 8/20/2019 4:32:18 PM | View | Proxy | SEC | Y 2018 | ||||||
| Hemispherx Biopharma Inc (AIM) | 8/15/2019 6:46:18 AM | View | Financials | Earnings | WIRE | 2Q 2019 | Rev $29,000 -12.1% | Assets $13,808,000 | EPS -$1.07 | Export Earnings Model | |
| HEMISPHERX BIOPHARMA INC (AIM) | 8/14/2019 4:48:05 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Rev: $29,000 -12.1% | Assets $13,808,000 | EPS -$1.07 | |
| Hemispherx Biopharma Inc (AIM) | 5/16/2019 8:32:22 AM | View | Financials | Earnings | WIRE | 1Q 2019 | Assets $15,965,000 | EPS -$2.91 | Export Earnings Model | ||
| HEMISPHERX BIOPHARMA INC (AIM) | 5/15/2019 4:35:11 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Assets $15,965,000 | EPS -$2.91 | ||
| HEMISPHERX BIOPHARMA INC (AIM) | 4/24/2019 6:06:03 AM | View | Proxy | SEC | Y 2018 | ||||||
| Hemispherx Biopharma Inc (AIM) | 4/1/2019 5:33:02 PM | View | Financials | Earnings | WIRE | Y 2018 | Rev $240,000 +380.0% | Assets $13,845,000 | EPS -$1.32 | Export Earnings Model | |
| HEMISPHERX BIOPHARMA INC (AIM) | 4/1/2019 5:17:41 PM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $367,000 -16.0% | Assets $13,845,000 | EPS -$9.77 | |
| Hemispherx Biopharma Inc (AIM) | 11/15/2018 9:04:59 AM | View | Financials | Earnings | WIRE | 3Q 2018 | Rev $38,000 -57.8% | Assets $15,170,000 | EPS -$2.87 | Export Earnings Model | |
| HEMISPHERX BIOPHARMA INC (AIM) | 11/14/2018 5:07:23 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Rev: $38,000 -57.8% | Assets $15,170,000 | EPS -$2.87 | |
| HEMISPHERX BIOPHARMA INC (AIM) | 8/14/2018 5:16:00 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Rev: $33,000 -84.5% | Assets $15,685,000 | EPS -$2.38 | |
| HEMISPHERX BIOPHARMA INC (AIM) | 8/3/2018 6:16:30 AM | View | Proxy | SEC | Y 2017 | ||||||
| HEMISPHERX BIOPHARMA INC (AIM) | 5/15/2018 5:55:53 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $56,000 -33.3% | Assets $16,260,000 | EPS -$0.07 | |
| HEMISPHERX BIOPHARMA INC (AIM) | 3/30/2018 5:36:22 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Rev: $437,000 +137.5% | Assets $14,207,000 | EPS -$0.29 | |
| HEMISPHERX BIOPHARMA INC (AIM) | 11/14/2017 3:44:48 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Rev: $90,000 +104.5% | Assets $14,725,000 | EPS -$0.04 | |
| HEMISPHERX BIOPHARMA INC (AIM) | 8/15/2017 9:29:34 AM | View | Financials | Earnings | SEC | 2Q 2017 | Rev $213,000 +610.0% | Assets $16,108,000 | EPS -$0.08 | Export Earnings Model | |
| HEMISPHERX BIOPHARMA INC (AIM) | 8/14/2017 5:26:21 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Rev: $213,000 +610.0% | Assets $16,108,000 | EPS -$0.08 | |
| HEMISPHERX BIOPHARMA INC (AIM) | 7/18/2017 5:31:28 PM | View | Proxy | SEC | Y 2016 | ||||||
| HEMISPHERX BIOPHARMA INC (AIM) | 5/15/2017 5:54:44 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Rev: $84,000 +7.7% | Assets $16,863,000 | EPS -$0.11 | |
| HEMISPHERX BIOPHARMA INC (AIM) | 4/3/2017 4:25:44 PM | View | Financials | Earnings | SEC | Y 2016 | Rev $32,000 -40.7% | Assets $18,873,000 | EPS -$0.04 | Export Earnings Model | |
| HEMISPHERX BIOPHARMA INC (AIM) | 3/31/2017 4:51:01 PM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Rev: $184,000 -30.8% | Assets $18,873,000 | EPS -$0.34 | |
| HEMISPHERX BIOPHARMA INC (AIM) | 11/14/2016 7:07:35 PM | View | Financials | Earnings | SEC | 3Q 2016 | Rev $44,000 -4.3% | Assets $21,576,000 | EPS -$0.13 | Export Earnings Model | |
| HEMISPHERX BIOPHARMA INC (AIM) | 11/14/2016 4:20:12 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Rev: $44,000 -4.3% | Assets $21,576,000 | EPS -$0.13 | |
| HEMISPHERX BIOPHARMA INC (AIM) | 8/15/2016 5:21:30 PM | View | Financials | Earnings | SEC | 2Q 2016 | Rev $30,000 -68.1% | Assets $21,918,000 | EPS -$0.06 | Export Earnings Model | |
| HEMISPHERX BIOPHARMA INC (AIM) | 8/15/2016 4:38:13 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Rev: $30,000 -68.1% | Assets $21,918,000 | EPS -$0.06 | |
| HEMISPHERX BIOPHARMA INC (AIM) | 6/27/2016 4:02:58 PM | View | Proxy | SEC | Y 2015 | ||||||
| HEMISPHERX BIOPHARMA INC (AIM) | 5/16/2016 5:13:55 PM | View | Financials | Earnings | SEC | 1Q 2016 | Rev $78,000 +8.3% | Assets $21,500,000 | EPS -$0.10 | Export Earnings Model | |
| HEMISPHERX BIOPHARMA INC (AIM) | 5/16/2016 5:06:04 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Rev: $78,000 +8.3% | Assets $21,500,000 | EPS -$0.10 | |
| HEMISPHERX BIOPHARMA INC (AIM) | 3/30/2016 6:02:27 AM | View | Financials | Earnings | SEC | Y 2015 | Rev $54,000 -32.5% | Assets $22,804,000 | EPS -$0.15 | Export Earnings Model | |
| HEMISPHERX BIOPHARMA INC (AIM) | 3/29/2016 4:20:34 PM | Micro | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Rev: $266,000 -32.5% | Assets $22,804,000 | EPS -$0.77 | |
| HEMISPHERX BIOPHARMA INC (AIM) | 11/16/2015 5:30:00 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Rev: $46,000 -48.9% | Assets $26,497,000 | EPS -$0.18 | |
| HEMISPHERX BIOPHARMA INC (AIM) | 8/12/2015 4:04:59 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Rev: $94,000 +30.6% | Assets $29,866,000 | EPS -$0.02 | |
| HEMISPHERX BIOPHARMA INC (AIM) | 8/10/2015 3:45:30 PM | View | Proxy | SEC | Y 2014 | ||||||
| HEMISPHERX BIOPHARMA INC (AIM) | 7/7/2015 2:04:14 PM | View | Proxy | SEC | Y 2014 | ||||||
| HEMISPHERX BIOPHARMA INC (AIM) | 5/12/2015 4:02:39 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Rev: $72,000 -52.6% | Assets $30,791,000 | EPS -$0.02 | |
| HEMISPHERX BIOPHARMA INC (AIM) | 3/19/2015 4:23:19 PM | Micro | View | Financials | 10-K | SEC | Y 2014 ending: 12/31/2014 | Rev: $394,000 +31.3% | Assets $29,440,000 | EPS -$1.11 | |
| HEMISPHERX BIOPHARMA INC (AIM) | 11/7/2014 4:06:44 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2014 ending: 9/30/2014 | Rev: $90,000 +25.0% | Assets $30,638,000 | EPS -$0.02 | |
| HEMISPHERX BIOPHARMA INC (AIM) | 10/10/2014 4:17:01 PM | View | Proxy | SEC | Y 2013 | ||||||
| HEMISPHERX BIOPHARMA INC (AIM) | 8/8/2014 4:04:26 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2014 ending: 6/30/2014 | Rev: $72,000 0.0% | Assets $33,549,000 | EPS -$0.03 | |
| HEMISPHERX BIOPHARMA INC (AIM) | 5/9/2014 4:04:17 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2014 ending: 3/31/2014 | Rev: $152,000 +81.0% | Assets $35,010,000 | EPS -$0.02 | |
| HEMISPHERX BIOPHARMA INC (AIM) | 3/14/2014 4:04:36 PM | Micro | View | Financials | 10-K | SEC | Y 2013 ending: 12/31/2013 | Rev: $300,000 -29.6% | Assets $31,867,000 | EPS -$0.10 | |
| HEMISPHERX BIOPHARMA INC (AIM) | 11/8/2013 4:04:16 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2013 ending: 9/30/2013 | Rev: $72,000 -7.7% | Assets $42,878,000 | EPS -$0.03 | |
| HEMISPHERX BIOPHARMA INC (AIM) | 9/16/2013 8:31:16 AM | View | Proxy | SEC | Y 2012 | ||||||
| HEMISPHERX BIOPHARMA INC (AIM) | 8/9/2013 4:10:30 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2013 ending: 6/30/2013 | Rev: $72,000 -26.5% | Assets $46,143,000 | EPS -$0.03 | |
| HEMISPHERX BIOPHARMA INC (AIM) | 5/8/2013 3:18:47 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2013 ending: 3/31/2013 | Rev: $84,000 -41.7% | Assets $51,659,000 | EPS -$0.02 | |
| HEMISPHERX BIOPHARMA INC (AIM) | 3/18/2013 3:03:53 PM | Micro | View | Financials | 10-K | SEC | Y 2012 ending: 12/31/2012 | Rev: $426,000 +32.3% | Assets $57,699,000 | EPS -$0.12 | |
| HEMISPHERX BIOPHARMA INC (AIM) | 11/2/2012 2:21:32 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2012 ending: 9/30/2012 | Rev: $78,000 -13.3% | Assets $48,578,000 | EPS -$0.05 | |
| HEMISPHERX BIOPHARMA INC (AIM) | 8/23/2012 3:45:25 PM | View | Proxy | SEC | Y 2011 | ||||||
| HEMISPHERX BIOPHARMA INC (AIM) | 8/8/2012 2:01:34 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2012 ending: 6/30/2012 | Rev: $98,000 +36.1% | Assets $41,110,000 | EPS -$0.02 | |
| HEMISPHERX BIOPHARMA INC (AIM) | 5/7/2012 4:18:09 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2012 ending: 3/31/2012 | Rev: $144,000 +71.4% | Assets $42,733,000 | EPS -$0.02 | |
| HEMISPHERX BIOPHARMA INC (AIM) | 3/14/2012 2:33:15 PM | Micro | View | Financials | 10-K | SEC | Y 2011 ending: 12/31/2011 | Rev: $322,000 +19.3% | Assets $43,513,000 | EPS -$0.07 | |
| HEMISPHERX BIOPHARMA INC (AIM) | 11/9/2011 11:39:57 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2011 ending: 9/30/2011 | Rev: $90,000 +28.6% | Assets $45,535,000 | EPS -$0.02 | |
| HEMISPHERX BIOPHARMA INC (AIM) | 9/16/2011 4:16:20 PM | View | Proxy | SEC | Y 2010 | ||||||
| HEMISPHERX BIOPHARMA INC (AIM) | 8/5/2011 4:30:28 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2011 ending: 6/30/2011 | Rev: $72,000 -12.2% | Assets $47,604,000 | EPS -$0.02 | |
| HEMISPHERX BIOPHARMA INC (AIM) | 2/4/2011 4:50:48 PM | View | Proxy | SEC | Y 2010 | ||||||
| HEMISPHERX BIOPHARMA INC (AIM) | 9/2/2009 9:08:32 AM | View | Proxy | SEC | Y 2008 | ||||||
| HEMISPHERX BIOPHARMA INC (AIM) | 5/22/2009 6:28:57 AM | View | Proxy | SEC | Y 2008 |